Top Ranked Momentum Stocks to Buy for April 11th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, April 11th:
ACI Worldwide, Inc. (ACIW): This provider of payment software products and services has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.5% over the last 60 days.
ACI Worldwide, Inc. Price and Consensus
ACI Worldwide, Inc. price-consensus-chart | ACI Worldwide, Inc. Quote
AAON's shares gained 5.2% over the last one month more than S&P 500’s gain of 3.8%. The company possesses a Momentum Score of B.
ACI Worldwide, Inc. Price
ACI Worldwide, Inc. price | ACI Worldwide, Inc. Quote
Avinger, Inc. (AVGR): This designer and manufacturer of image-guided and catheter-based systems has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 43.3% over the last 60 days.
Avinger, Inc. Price and Consensus
Avinger, Inc. price-consensus-chart | Avinger, Inc. Quote
Avinger's shares gained 29.7% over the last one month. The company possesses a Momentum Score of A.
Avinger, Inc. Price
Avinger, Inc. price | Avinger, Inc. Quote
Acacia Communications, Inc. (ACIA): This developer and manufacturer of high-speed coherent optical interconnect products has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.7% over the last 60 days.
Acacia Communications, Inc. Price and Consensus
Acacia Communications, Inc. price-consensus-chart | Acacia Communications, Inc. Quote
Acacia Communications' shares gained 11.1% over the last one month. The company possesses a Momentum Score of B.
Acacia Communications, Inc. Price
Acacia Communications, Inc. price | Acacia Communications, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Avinger, Inc. (AVGR) : Free Stock Analysis Report
ACI Worldwide, Inc. (ACIW) : Free Stock Analysis Report
Acacia Communications, Inc. (ACIA) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research